论文部分内容阅读
目的探讨经颅超声溶栓治疗急性脑梗死的临床效果。方法 57例急性脑梗死患者随机分成治疗组(35例)与对照组(22例)。对照组患者给予奥扎格雷钠、复方丹参注射液与辛伐他汀进行治疗,同时控制患者血压、血糖等;治疗组患者在对照组基础上给予经颅超声溶栓治疗仪治疗。比较两组患者的临床疗效。结果治疗组患者总有效率(94.29%)与治疗后神经功能评分(13.28±10.37)分均明显优于对照组(72.73%)、(19.59±10.35)分,两组比较差异有统计学意义(P<0.05)。结论采用经颅超声溶栓治疗急性脑梗死疗效显著,能有效改善患者不良体征,值得临床推广。
Objective To investigate the clinical effect of transcranial ultrasound thrombolysis in acute cerebral infarction. Methods 57 patients with acute cerebral infarction were randomly divided into treatment group (35 cases) and control group (22 cases). Patients in the control group were given sodium ozagrel, compound salvia miltiorrhiza injection and simvastatin, while blood pressure and blood sugar were controlled. Patients in the treatment group were treated with transcranial ultrasound thrombolysis on the basis of the control group. The clinical efficacy of the two groups was compared. Results The total effective rate (94.29%) and postoperative neurological function score (13.28 ± 10.37) in the treatment group were significantly better than those in the control group (72.73%) and (19.59 ± 10.35), respectively, with significant difference between the two groups P <0.05). Conclusion Transcranial ultrasound thrombolytic therapy of acute cerebral infarction significant effect, can effectively improve the patient’s bad signs, is worth clinical promotion.